VA declines broad coverage for new J&J depression drug touted by Trump
STAT
Many experts have embraced the medication, known as esketamine, but some watchdog groups have expressed concerns about its effectiveness and safety.
Clinical and Molecular Allergy
Hace 12 horas
No hay comentarios:
Publicar un comentario